Document is current
Any future updates will be listed below
-
Authors
Sims, Tracy J. https://orcid.org/0000-0001-6822-2927
Chinthammit, Chanadda
Constantine, Melissa L.
Bushnell, Donald M.
Spaepen, Erik
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 29 August 2025
First Online: 20 September 2025
Declarations
:
: Tracy J. Sims and Chanadda Chinthammit are employees and stockholders of Eli Lilly and Company, which sponsored this study and the journal’s Rapid Service Fee. Donald M. Bushnell is an employee of Thermo Fisher Scientific PPD Evidera, which received funding from Eli Lilly and Company to conduct this study. Melissa L. Constantine is affiliated with the University of Minnesota School of Public Heath, Minneapolis, MN, and is a former employee of Thermo Fisher Scientific PPD Evidera. Erik Spaepen has received consulting fees from Eli Lilly and Company for work as a statistician.
: The Western-Copernicus Group institutional review board (tracking number: 20231182) approved the study protocols and informed consent forms. The study was conducted in accordance with ethical principles originating in the Declaration of Helsinki and consistent with Good Pharmacoepidemiology Practices. Each participant provided informed consent at study entry before they responded to survey questions.
